These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulated cutaneous gene delivery: the skin as a bioreactor. Cao T; Wang XJ; Roop DR Hum Gene Ther; 2000 Nov; 11(16):2297-300. PubMed ID: 11084689 [TBL] [Abstract][Full Text] [Related]
3. The genodermatoses: candidate diseases for gene therapy. Uitto J; Pulkkinen L Hum Gene Ther; 2000 Nov; 11(16):2267-75. PubMed ID: 11084685 [TBL] [Abstract][Full Text] [Related]
12. Host immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes. Lu Z; Ghazizadeh S Exp Dermatol; 2005 Oct; 14(10):727-35. PubMed ID: 16176280 [TBL] [Abstract][Full Text] [Related]
14. Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy. Larcher F; Dellambra E; Rico L; Bondanza S; Murillas R; Cattoglio C; Mavilio F; Jorcano JL; Zambruno G; Del Rio M Mol Ther; 2007 Sep; 15(9):1670-6. PubMed ID: 17579576 [TBL] [Abstract][Full Text] [Related]
15. In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy. Ghazizadeh S; Harrington R; Taichman L Gene Ther; 1999 Jul; 6(7):1267-75. PubMed ID: 10455435 [TBL] [Abstract][Full Text] [Related]
16. Gene delivery to the epidermis. Trainer AH; Alexander MY Hum Mol Genet; 1997; 6(10):1761-7. PubMed ID: 9300669 [TBL] [Abstract][Full Text] [Related]
17. A preclinical model for the analysis of genetically modified human skin in vivo. Del Rio M; Larcher F; Serrano F; Meana A; Muñoz M; Garcia M; Muñoz E; Martin C; Bernad A; Jorcano JL Hum Gene Ther; 2002 May; 13(8):959-68. PubMed ID: 12031128 [TBL] [Abstract][Full Text] [Related]